Corient Private Wealth
AMPH icon

Corient Private Wealth’s Amphastar Pharmaceuticals AMPH Stock Holding History

Corient Private Wealth’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23,178
Closed -$621K – 2847
2025
Q4 		$621K Buy
23,178
+7,455
+47% +$192K ﹤0.01% 2180
2025
Q3 		$419K Buy
+15,723
New +$406K ﹤0.01% 1911
2025
Q2 		– Sell
-7,230
Closed -$210K – 2433
2025
Q1 		$210K Sell
7,230
-8,151
-53% -$260K ﹤0.01% 2044
2024
Q4 		$571K Buy
15,381
+34
+0.2% +$1.55K ﹤0.01% 1545
2024
Q3 		$745K Buy
15,347
+10
+0.1% +$439 ﹤0.01% 1544
2024
Q2 		$613K Sell
15,337
-61
-0.4% -$2.53K ﹤0.01% 1541
2024
Q1 		$676K Sell
15,398
-2
-0% -$103 ﹤0.01% 1477
2023
Q4 		$952K Sell
15,400
-4,942
-24% -$260K ﹤0.01% 1305
2023
Q3 		$936K Sell
20,342
-3
-0% -$164 ﹤0.01% 1217
2023
Q2 		$1.17M Buy
20,345
+641
+3% +$28.4K ﹤0.01% 1094
2023
Q1 		$739K Buy
19,704
+7,104
+56% +$233K ﹤0.01% 1213
2022
Q4 		$353K Buy
+12,600
New +$366K ﹤0.01% 1273

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Corient Private Wealth's AMPH Position: Q1 2026 in Review

Corient Private Wealth sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2026, closing a stake of 23,178 shares — an estimated $621K sold.

Corient Private Wealth first reported a position in AMPH in Q4 2022 and held it in 12 quarters. The position peaked at $1.17M in Q2 2023. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Corient Private Wealth reported no remaining Amphastar Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Corient Private Wealth sold 23,178 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $621K.
  • Corient Private Wealth first reported a position in Amphastar Pharmaceuticals in Q4 2022 and held it in 12 quarters.
  • Corient Private Wealth's Amphastar Pharmaceuticals position peaked at $1.17M in Q2 2023.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.